BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 28179447)

  • 1. DIAGNOSIS OF ENDOCRINE DISEASE: Differentiation of pathologic/neoplastic hypercortisolism (Cushing's syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing's syndrome).
    Findling JW; Raff H
    Eur J Endocrinol; 2017 May; 176(5):R205-R216. PubMed ID: 28179447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The difficulties of pseudo-Cushing's syndrome (or "non-neoplastic hypercortisolism").
    Chabre O
    Ann Endocrinol (Paris); 2018 Jun; 79(3):138-145. PubMed ID: 29716734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pitfalls in the diagnosis and management of Cushing's syndrome.
    Bansal V; El Asmar N; Selman WR; Arafah BM
    Neurosurg Focus; 2015 Feb; 38(2):E4. PubMed ID: 25639322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cushing's syndrome: diagnostic exploration].
    Tabarin A; Roger P
    Presse Med; 1994 Jan 8-15; 23(1):43-8. PubMed ID: 8127815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology and diagnosis of Cushing's syndrome.
    Miyachi Y
    Biomed Pharmacother; 2000 Jun; 54 Suppl 1():113s-117s. PubMed ID: 10915006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cushing's Syndrome: Screening and Diagnosis.
    Ceccato F; Boscaro M
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):209-15. PubMed ID: 27160717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome.
    Findling JW; Kehoe ME; Shaker JL; Raff H
    J Clin Endocrinol Metab; 1991 Aug; 73(2):408-13. PubMed ID: 1649842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests.
    Alwani RA; Schmit Jongbloed LW; de Jong FH; van der Lely AJ; de Herder WW; Feelders RA
    Eur J Endocrinol; 2014 Apr; 170(4):477-86. PubMed ID: 24394725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of pathologic/neoplastic hypercortisolism (Cushing's syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing's syndrome): Letter to the Editor.
    Thomson M
    Eur J Endocrinol; 2018 Mar; 178(3):L1-L2. PubMed ID: 29440267
    [No Abstract]   [Full Text] [Related]  

  • 13. Late-night salivary cortisol as a screening test for Cushing's syndrome.
    Raff H; Raff JL; Findling JW
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2681-6. PubMed ID: 9709931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of normal tests assessing hypercortisolism in subjects with mild and episodic Cushing's syndrome suggests that the paradigm for diagnosis and exclusion of Cushing's syndrome requires multiple testing.
    Friedman TC; Ghods DE; Shahinian HK; Zachery L; Shayesteh N; Seasholtz S; Zuckerbraun E; Lee ML; McCutcheon IE
    Horm Metab Res; 2010 Nov; 42(12):874-81. PubMed ID: 20803415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and differential diagnosis of Cushing's syndrome.
    Findling JW; Raff H
    Endocrinol Metab Clin North Am; 2001 Sep; 30(3):729-47. PubMed ID: 11571938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis and management of Cushing's syndrome.
    Tsigos C; Chrousos GP
    Annu Rev Med; 1996; 47():443-61. PubMed ID: 8712794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic tests for Cushing's syndrome.
    Nieman LK
    Ann N Y Acad Sci; 2002 Sep; 970():112-8. PubMed ID: 12381546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum total prostate-specific antigen assay in women with Cushing's disease or alcohol-dependent pseudo-Cushing's State.
    Coiro V; Volpi R; Galli P; Manfredi G; Magotti MG; Saccani-Jotti G; Chiodera P
    Horm Res; 2004; 61(3):148-52. PubMed ID: 14685016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism.
    Friedman TC
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):356-60. PubMed ID: 16915537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cushing's syndrome: update on signs, symptoms and biochemical screening.
    Nieman LK
    Eur J Endocrinol; 2015 Oct; 173(4):M33-8. PubMed ID: 26156970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.